Neurocrine Biosciences
NBIX
#1497
Rank
A$20.62 B
Marketcap
A$202.95
Share price
-1.55%
Change (1 day)
-2.46%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Annual Reports

Thumbnail Neurocrine Biosciences
 Annual Report 2025

Annual Report 2025

Language: English

View Annual Report
Thumbnail Neurocrine Biosciences
 Annual Report 2024

Annual Report 2024

Language: English

View Annual Report
Thumbnail Neurocrine Biosciences
 Annual Report 2022

Annual Report 2022

Language: English

View Annual Report
Thumbnail Neurocrine Biosciences
 Annual Report 2021

Annual Report 2021

Language: English

View Annual Report
Thumbnail Neurocrine Biosciences
 Annual Report 2020

Annual Report 2020

Language: English

View Annual Report
Thumbnail Neurocrine Biosciences
 Annual Report 2019

Annual Report 2019

Language: English

View Annual Report
Thumbnail Neurocrine Biosciences
 Annual Report 2018

Annual Report 2018

Language: English

View Annual Report
Thumbnail Neurocrine Biosciences
 Annual Report 2017

Annual Report 2017

Language: English

View Annual Report
Thumbnail Neurocrine Biosciences
 Annual Report 2016

Annual Report 2016

Language: English

View Annual Report